PTHS peer analysis
PTHS (PTHS) against its competitors: price, today's move, 1-year return and market value side by side.
- PTHS's peers: CING (Cingulate), ENLV (Enlivex), KAPA (Kairos Pharma), LEXX (Lexaria Bioscience), LSTA (Lisata Therapeutics), MTVA (MetaVia), PASG (Passage Bio).
PTHS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CING Cingulate | $4.61 | -12.36% | 34.80% | $68.98M |
| ENLV Enlivex | $1.17 | -2.50% | -91.69% | $19.69M |
| KAPA Kairos Pharma | $0.46 | 3.79% | -90.86% | $1.55M |
| LEXX Lexaria Bioscience | $4.49 | 4.91% | -72.79% | $7.42M |
| LSTA Lisata Therapeutics | $0.91 | -7.15% | -55.17% | $9.83M |
| MTVA MetaVia | $1.07 | 0.94% | -87.27% | $7.21M |
| PASG Passage Bio | $3.61 | -12.70% | -54.19% | $11.62M |
| PTHS Pelthos Therapeutics | $6.99 | -1.55% | -79.01% | $27.48M |